770-729-2992
RayBiotech offers binding assays for studying receptor-ligand or drug-target interactions. Using an ELISA-like format, the protein or small molecule of interest is coated on a 96-well microplate and potential inhibitors are then added in the presence of the interacting molecule. This assay enables rapid, high throughput, in-vitro screening of potential inhibitors. Browse ready-made kits to query Spike-receptor interactions that facilitate SARS-CoV-2 viral entry into host cells, as well as to detect drug antibodies (DA) and anti-drug antibodies (ADA).